UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for "Paradoxical" Anxiety/Jitteriness syndrome-Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution

Frontiers in psychiatry, 2023-03, Vol.14, p.1095244-1095244

Bonnet, Udo

2023

Link zum Volltext

Verfügbarkeit prüfen

How much of ketamine's antidepressant response is shared with ethanol?

British journal of psychiatry, 2016-11, Vol.209 (5), p.434-435

Bonnet, Udo

2016

Link zum Volltext

Verfügbarkeit prüfen

Do patients’ resilience and subjective illness representation predict the outcome of a routine inpatient treatment program of major depressive disorder?

European archives of psychiatry and clinical neuroscience, 2021-10, Vol.271 (7), p.1309-1317

2021

Link zum Volltext

Verfügbarkeit prüfen

Correspondence

Deutsches Ärzteblatt international, 2023-03

Bonnet, Udo

2023

Link zum Volltext

Verfügbarkeit prüfen

Cannabis hyperemesis syndrome recovers completely when the use of cannabis or synthetic cannabinoids is permanently discontinued—cyclic vomiting syndrome does not

Gastroenterology (New York, N.Y. 1943), 2024-06

Bonnet, Udo

2024

Link zum Volltext

Verfügbarkeit prüfen

Gabapentinoids: condemned without sufficient evidence?

The Lancet regional health. Europe, 2023-05, Vol.28, p.100629-100629, Article 100629

2023

Link zum Volltext

Verfügbarkeit prüfen

Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth

Pain and therapy, 2020-12, Vol.9 (2), p.441-452

2020

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials

Frontiers in psychiatry, 2022-06, Vol.13, p.867878-867878

2022

Link zum Volltext

Verfügbarkeit prüfen

Antidepressants for prevention of severe COVID-19, Long COVID and outlook for other viral diseases

Frontiers in medicine, 2024-02, Vol.11, p.1305184-1305184

2024

Link zum Volltext

Verfügbarkeit prüfen

Subjective reward processing and catechol-O- methyltransferase Val158Met polymorphism as potential research domain criteria in addiction: A pilot study

Frontiers in psychiatry, 2022-10, Vol.13, p.992657-992657

2022

Link zum Volltext

Verfügbarkeit prüfen

Opiate maintenance patients’ attitudes and self-reported adherence to protective measures against SARS-CoV-2 infections

Frontiers in psychiatry, 2023-09, Vol.14, p.1254053-1254053

2023

Link zum Volltext

Verfügbarkeit prüfen

Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany

Frontiers in psychiatry, 2021-04, Vol.12, p.648273-648273

2021

Link zum Volltext

Verfügbarkeit prüfen

Gabapentinoid-related deaths: An alarming global trend or just a special challenge within the long tail of the giant opioid epidemic?

Lancet Regional Health - Americas (Online), 2022-07, Vol.11, p.100309-100309, Article 100309

2022

Link zum Volltext

Verfügbarkeit prüfen

Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates

Frontiers in psychiatry, 2022-11, Vol.13, p.1041762-1041762

2022

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 und Long-COVID mit Antidepressiva verhindern?: Potenzial, die Infektion zu bremsen und die Resilienz zu stärken

DNP – Die Neurologie & Psychiatrie, 2023-10, Vol.24 (5), p.34-39

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction

Journal of psychoactive drugs, 2015-08, Vol.47 (4), p.276-285

Bonnet, Udo

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment

Frontiers in psychiatry, 2020-07, Vol.11, p.569-569

2020

Link zum Volltext

Verfügbarkeit prüfen

The sour side of vitamin C might mediate neuroprotective, anticonvulsive and antidepressant-like effects

Medical hypotheses, 2019-10, Vol.131, p.109320-109320, Article 109320

Bonnet, Udo

2019

Link zum Volltext

Verfügbarkeit prüfen

Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome

Medical principles and practice, 2022-12, Vol.31 (5), p.497-498

Bonnet, Udo

2022

Link zum Volltext

Verfügbarkeit prüfen

Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

Frontiers in psychiatry, 2020-12, Vol.11, p.598150-598150

2020

Link zum Volltext

Verfügbarkeit prüfen

Motives for and Consequences of Long-term Prescription of Z-Drugs

Deutsches Ärzteblatt international, 2023-03, Vol.120 (9), p.145-145

Bonnet, Udo

2023

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review

Journal of clinical psychopharmacology, 2022-05, Vol.42 (3), p.284

2022

Link zum Volltext

Verfügbarkeit prüfen

Cannabis hyperemesis syndrome: A specific cannabis‐related disorder?

Neurogastroenterology and motility, 2020-01, Vol.32 (1), p.e13723-n/a

Bonnet, Udo

2020

Link zum Volltext

Verfügbarkeit prüfen

Serotonin deficiency and psychiatric long COVID: both caused specifically by the virus itself or an adaptive general stress response?

European archives of psychiatry and clinical neuroscience, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

How much alcohol is in ketamine's antidepressant action?

Life sciences (1973), 2017-01, Vol.168, p.54-57

Bonnet, Udo

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Englisch
(112)
Deutsch
(19)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for "Paradoxical" Anxiety/Jitteriness syndrome-Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution

How much of ketamine's antidepressant response is shared with ethanol?

Do patients’ resilience and subjective illness representation predict the outcome of a routine inpatient treatment program of major depressive disorder?

Correspondence

Cannabis hyperemesis syndrome recovers completely when the use of cannabis or synthetic cannabinoids is permanently discontinued—cyclic vomiting syndrome does not

Gabapentinoids: condemned without sufficient evidence?

Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth

Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials

Antidepressants for prevention of severe COVID-19, Long COVID and outlook for other viral diseases

Subjective reward processing and catechol-O- methyltransferase Val158Met polymorphism as potential research domain criteria in addiction: A pilot study

Opiate maintenance patients’ attitudes and self-reported adherence to protective measures against SARS-CoV-2 infections

Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany

Gabapentinoid-related deaths: An alarming global trend or just a special challenge within the long tail of the giant opioid epidemic?

Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates

COVID-19 und Long-COVID mit Antidepressiva verhindern?: Potenzial, die Infektion zu bremsen und die Resilienz zu stärken

Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment

The sour side of vitamin C might mediate neuroprotective, anticonvulsive and antidepressant-like effects

Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome

Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

Motives for and Consequences of Long-term Prescription of Z-Drugs

COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review

Cannabis hyperemesis syndrome: A specific cannabis‐related disorder?

Serotonin deficiency and psychiatric long COVID: both caused specifically by the virus itself or an adaptive general stress response?

How much alcohol is in ketamine's antidepressant action?

Suchergebnisse filtern